All In MedTech

FDA Clearance Tracker · P040014

IBI THERAPY CARDIAC ABLATION SYSTEM ERS/ 1500T RF GENERATOR

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jan 14, 2005 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Jan 14, 2005

Approved

Time to decision

305 days

Received Mar 15, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P040014
Device name
IBI THERAPY CARDIAC ABLATION SYSTEM ERS/ 1500T RF GENERATOR
Applicant location
Irvine, CA
Received
Mar 15, 2004
Decided
Jan 14, 2005
Decision
Approved
Supplements
50 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LPB

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE IBI THERAPY CARDIAC ABLATION SYSTEM. THE DEVICE IS INDICATED FOR MAPPING AND FOR USE WITH A COMPATIBLE RF GENERATOR FOR: INTERRUPTION OF ACCESSORY ATRIOVENTRICULAR (AV) CONDUCTION PATHWAYS ASSOCIATED WITH TACHYCARDIA; THE TREATMENT OF AV NODAL RE-ENTRANT TACHYCARDIA (AVNRT); OR CREATION OF COMPLETE AV NODAL BLOCK IN PATIENTS WITH A DIFFICULT TO CONTROL VENTRICULAR RESPONSE TO AN ATRIAL ARRHYTHMIA.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LPB. The earliest in FDA's data is P920047, decided Oct 28, 1994.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Irvine Biomedical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.